Pharmaceutical companies looking to better understand their customer base are increasingly turning to PeakData, which has just secured $12.1M in Series A funding. The company’s agile targeting and segmentation SaaS platform provides crucial insights, a capability that has already attracted more than half of the top 20 pharmaceutical firms as clients.
With a growing international presence, PeakData currently engages over 50 staff across its offices in the USA, Germany, UK, Poland, Netherlands, and Switzerland, solidifying its position in the global pharma tech landscape.
